Insiders Biogen Inc.

Equities

BIIB

US09062X1037

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
181.30 ^USD	-0.37%		-0.43%	+18.56%

Dec. 05	Stoke Therapeutics, Inc. and Biogen Inc. Present Data That Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome	CI
Dec. 05	Stoke Therapeutics and Biogen present data that further support the disease-modifying potential of zorevunersen	RE

Insiders

Tyra Biosciences, Inc. Appoints Heather Faulds as Chief Regulatory Officer, Effective December 8, 2025	Dec. 01	CI
Exelixis Insider Sold Shares Worth $4,355,000, According to a Recent SEC Filing	Nov. 14	MT
Climb Bio, Inc. Announces Executive Appointments	Oct. 21	CI
Mallinckrodt plc Announces Executive Changes	Sep. 22	CI
Innovent Biologics, Inc. Appoints Stephen A. Sherwin as an Independent Non-Executive Director and A Member of the Strategy Committee of the Board, Effective August 26, 2025	Aug. 26	CI
Biogen Insider Sold Shares Worth $300,105, According to a Recent SEC Filing	Jul. 16	MT
Satellos Bioscience Inc. Appoints Wildon Farwell as Chief Medical Officer	Jul. 16	CI
Indivior PLC Appoints Tony Kingsley as Independent Non-Executive Director, Effective July 1, 2025	Jun. 24	CI
Ionis Pharmaceuticals, Inc. Announces Executive Changes	Jun. 12	CI
FibroGen, Inc. Announces the Appointment of Michael Kauffman to Its Board of Directors, Effective June 4, 2025	Jun. 09	CI
Entrada Therapeutics, Inc. Appoints Maha Radhakrishnan, M.D., to Its Board of Directors	Jun. 03	CI
Exelixis Insider Sold Shares Worth $1,619,130, According to a Recent SEC Filing	May. 19	MT
Ovid Therapeutics Inc. Appoints Stelios Papadopoulos to Its Board of Directors and Member of Audit and Compensation Committees	Mar. 03	CI
Indivior Parts Ways With CEO as Leadership Shakeup Continues	Feb. 27	DJ
EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO	Jan. 28	AN
Shield Therapeutics plc Appoints Anders Lundstrom as CEO, Effective 1 February 2025	Jan. 27	CI
Biogen Inc. Announces Executive Changes Effective March 1, 2025	Jan. 15	CI
Biogen Inc. Announces Appointment of Adam Feire as Head of Business Development and External Innovation	Jan. 10	CI
Biogen Inc. Appoints Daniel Quirk as Chief Medical Officer and Head of Medical Affairs	24-10-29	CI
Biogen Finance Chief Michael McDonnell to Retire; Successor Named	24-10-28	MT
Biogen Inc. Announces Chief Financial Officer Changes	24-10-28	CI
Biogen Inc. Announces Executive Changes	24-10-28	CI
Incannex Healthcare Inc. Announces Appointment of Dr. Lou Barbato as Chief Medical Officer	24-10-24	CI
Oculis Holding AG Announces Appointment of Daniel S. Char as Chief Legal Officer	24-10-02	CI
Sector Update: Health Care Stocks Fall Late Afternoon	24-09-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Biogen Inc.

Equities

BIIB

US09062X1037

Pharmaceuticals

Insiders

Filters